Menu
  • Home
  • About
  • Distributors
  • Investors
Pressure BioSciences Inc
Menu
  • Technology
  • Products
  • Publications
  • Contract Services
  • Contact

Press Releases

Investors
  • Overview
  • News / Events
    • Press Releases
    • Audio and Video
    • Email Alerts
  • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All Filings
    • Annual Reports
    • Proxy Statements
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

News / Events

  • Press Releases
  • Audio and Video
  • Email Alerts

Pressure BioSciences Announces Commercial Release of the HUB880 Explorer

Sep 13, 2018

Pressure BioSciences Awarded Key U.S. Patent for Novel High-Pressure Flow-Through Microfluidic Sample Preparation Device

Aug 30, 2018

Pressure BioSciences, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update

Aug 15, 2018

Pressure BioSciences, Inc. to Discuss Second Quarter 2018 Financial Results and Provide Business Update

Aug 10, 2018

Pressure BioSciences, Inc. President and CEO, Richard T. Schumacher, Discusses Recent Company Achievements with Everett Jolly on Uptick Newswire’s “Stock Day” Podcast

Aug 9, 2018

Pressure BioSciences Developing Potential Breakthrough Processing Method for High Quality, Shelf Stable Milk and Other Dairy Products

Jul 19, 2018

Everett Jolly, Host of “Stock Day” Welcomes Richard T. Schumacher of Pressure BioSciences Back on the Show to Discuss Significant Debt to Equity Conversions and other Recent Accomplishments

Jun 18, 2018

Pressure BioSciences Converts Additional $7.24M of Debt into Equity: Total Conversions Exceed $13.6M in Past 30 Days

Jun 12, 2018

Pressure BioSciences, Inc. Reports First Quarter 2018 Financial Results and Provides Business Update

May 15, 2018

Richard T. Schumacher, CEO of Pressure BioSciences, Joins Everett Jolly on Uptick Newswire’s “Stock Day” Podcast to Discuss Important New Contract from International Bio-Therapeutic Company and Other Recent Achievements

May 10, 2018
RSS
    • 1...
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • ...36

    Browse Our Site

    • Home
    • About
    • Distributors
    • Investors
    • Technology
    • Products
    • Publications
    • Contract Services
    • Contact

    Visit Us

    • Corporate Office
    • Pressure BioSciences, Inc.
    • 14 Norfolk Avenue
    • South Easton, MA 02375
    • Research & Development Laboratory
    • Pressure BioSciences, Inc.
    • Suite 1950
    • 200 Boston Avenue
    • Medford, MA 02155

    Connect With Us

    Talk To Us

    • P (508) 230.1828
    • F (508) 230.1829
    • E info@pressurebiosciences.com
    • SEND US A MESSAGE
    • Privacy Policy
    • Returns & Refunds
    • Terms & Conditions/Delivery & Shipment
    • Disclaimer

    © 2021 Pressure BioSciences, Inc. All Rights Reserved. Website by Interactive Palette